|
PF-37937 |
MALANIL 250 mg/100 mg Tabletas recubiertas simples |
2016-08-22 |
|
Glaxosmithkline Inc |
Canadá
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30634 |
OTOSPORIN Suspensión ótica |
2018-05-29 |
|
The Wellcome Foundation Limited |
Canadá
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31264 |
ZIAGEN 20 mg/ mL Solución oral |
2023-09-03 |
|
ViiV Healthcare ULC |
Canadá
|
J.I.Cohen, S.A. |
Amicelco |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31311 |
3 TC 10 mg/ mL Solución Oral |
2018-09-18 |
|
ViiV Healthcare UK Limited |
Canadá
|
J.I.Cohen, S.A. |
Amicelco |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30182 |
ZOFRAN 4 mg/5 mL jarabe |
2008-04-03 |
|
Glaxosmithkline Inc |
Guatemala
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52288 |
LAMICTAL 2 mg Tabletas dispersables y/o masticables |
2025-12-16 |
|
GlaxoSmithKline LLC |
Estados Unidos de América
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52808 |
SERETIDE DISKUS 50-500 mcg / dosis Polvo para Inhalación |
2026-01-19 |
|
GlaxoSmithKline LLC |
Estados Unidos de América
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52809 |
SERETIDE DISKUS 50-100 mcg / dosis Polvo para Inhalación |
2026-01-19 |
|
GlaxoSmithKline LLC |
Estados Unidos de América
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54906 |
SERETIDE DISKUS 50-250 mcg / dosis Polvo para Inhalación |
2023-01-30 |
|
Glaxo Wellcome UK Limited |
Estados Unidos de América
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-60488 |
DOVATO Comprimidos recubiertos con película |
2026-12-22 |
|
ViiV Healthcare B.V., |
Estados Unidos de América
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|